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The addition of the amphipathic polycationic antibiotic polymyxin B to a suspension of rabbit neutrophils 
results in inhibition of the agonist (secretion of secondary granules) and antagonist (inhibition of chemo- 
tactic factor induced degranulation) properties of phorbol 12-myristate 13-acetate. On the other hand, poly- 
myxin B does not inhibit the degranulation of the neutrophils that is induced by chemotactic factors. These 
results imply that the role of protein kinase C in the initiation of neutrophil functions in response to the 
addition of chemotactic factors is less critical than previously thought. In addition, the reversal of the inhibi- 
tory properties of phorbol esters by polymyxin B indicates that the former are mediated by the ability of 
the tumor promoters to activate protein kinase C. These results thus strengthen the hypothesis that protein 
kinase C plays important roles in the regulation (as contrasted to initiation) of neutrophil functions. 
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1. INTRODUCTION 
The activation and/or intracellular translocation 
of protein kinase C figures prominently in most 
current models of non-muscle cell activation [l]. 
The evidence implicating this enzyme in the above 
functions includes its presence in the target tissues, 
the demonstration of the stimulation of its activity 
by various agonists, and of the biological activities 
of phorbol diesters. The actions of the latter com- 
pounds are generally thought to result from their 
ability to bind to and activate protein kinase C. 
The above evidence, however compelling, is essen- 
tially of a correlative nature in the absence of the 
definition of the biological roles of the substrates 
of protein kinase C and thus deserves additional 
probing. 
hibitory activity of the antibiotic towards protein 
kinase C [2-41. The results to be presented indicate 
that while polymyxin B is a potent inhibitor of the 
degranulation of rabbit neutrophils induced by 
phorbol 12-myristate 13-acetate (PMA), it, in con- 
trast, does not antagonize the secretory activity of 
the formylated oligopeptides chemoattractants. In 
addition, pretreatment of the neutrophils with 
polymyxin B prevents the inhibition of respon- 
siveness towards the chemotactic factor that is in- 
duced by PMA. The implication of these results 
for the role of protein kinase C in the initiation and 
maintenance of stimulated neutrophil functions 
will be discussed. 
2. MATERIALS AND METHODS 
In an effort to examine further the potential in- Rabbit peritoneal neutrophils obtained 4 or 16 h 
volvement of protein kinase C in the activation of after the injection of sterile glycogen solutions 
the polymorphonuclear neutrophilic leukocytes were used throughout these experiments. They 
(neutrophils), we have examined the effects of were collected, handled and resuspended in Hanks’ 
polymyxin B on the responses of these cells to balanced salt solution containing no added mag- 
chemoattractants and phorbol diesters. These nesium or protein as reported [5]. 
studies were prompted by the reports of the in- Neutrophil degranulation was monitored by 
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following the extracellular release of N-acetyl-& 
glucosaminidase, lysozyme and lactate dehydro- 
genase. The release of the latter, an index of cell 
viability, did not differ significantly between the 
untreated control cell samples and the treated 
ones, and did not exceed 7% of the total cell con- 
tent of this enzyme. Unless otherwise noted, the 
characteristics of the release of the 2 granular en- 
zymes as induced by fMet-Leu-Phe closely paral- 
leled each other. 
Polymyxin B was purchased from Sigma (St. 
Louis, MO), fMet-Leu-Phe from Peninsula Labs. 
(San Carolos, CA) and PMA from CMC Cancer 
Chemicals (Brewster, NY). 
3. RESULTS AND DISCUSSION 
The cyclic polycationic peptide antibiotic poly- 
myxin B has recently been shown to be a potent in- 
hibitor of the calcium- and phospholipid-dependent 
protein kinase generally referred to as protein 
kinase C [2,3]. Polymyxin B has also been shown 
to inhibit the secretion of amylase from isolated 
pancreatic acini [3] and the stimulation of protein 
kinase C activity and proliferation induced by 
phorbol esters in B lymphocytes [4]. As protein 
kinase C had been implicated in the mechanism of 
initiation and regulation of neutrophil function by 
various agents including chemoattractants and 
phorbol esters [6-121, it was thus of immediate 
relevance to examine the effects of polymyxin B on 
neutrophil degranulation induced by these 2 classes 
of agonists. 
The addition of polymyxin B prior to that of 
PMA reduces in a concentration-dependent man- 
ner the secretion of lysozyme from the neutrophils 
(fig.1). The IGO of the inhibition of lysozyme 
release by polymyxin B, obtained at 100 ng/ml 
PMA, is about 0.1 mM. Note that the basal level 
of lysozyme release, that is observed following the 
30 min incubation in the absence of any secreta- 
gogue, is also reduced in the presence of the an- 
tibiotic. In contrast (fig.2), neutrophil degranula- 
tion induced by the formylated peptide chemoat- 
tractant fMet-Leu-Phe is not inhibited by poly- 
myxin B. In fact, the antibiotic potentiates lightly, 
though consistently, the release of N-acetyl-& 
glucosaminidate from the cells while it leaves unaf- 
fected that of lysozyme. Preliminary experiments 
have likewise shown that the secretory responses to 
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Fig. 1. Concentration dependence of the inhibitory effect 
of polymyxin B on the secretion of lysozyme induced by 
PMA in rabbit neutrophils. The concentration of PMA 
was 100 ng/ml; the incubation time with the phorbol 
ester, 30 min and the preincubation time with polymyxin 
B, 10 min. The data represent he mean k SE of 3 ex- 
periments each carried out in duplicates. 
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Fig.2. Effect of polymyxin B on the degranulation of 
rabbit neutrophils as induced by fMet-Leu-Phe and 
cytochalasin B. The concentration of cytochalasin B was 
2.5 fig/ml, and the incubation times with the chemotac- 
tic factor and the antibiotic 5 and 10 min, respectively. 
The data represent the mean f SE of at least 7 ex- 
periments each carried out in duplicates. 
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leukotriene B4 and platelet activating factor are not 
inhibited by preincubation with polymyxin B. 
Phorbol esters such as PMA have recently been 
shown to inhibit the responses of a variety of cells 
if added a few minutes before the respective 
agonists. In the neutrophils, PMA inhibits the 
ability of several chemoattractants to induce 
secretory and oxidative responses and to raise the 
cytoplasmic levels of calcium [9,10,12]. The 
mechanism by which PMA expresses its antagonist 
activity is not known. It is thought however to de- 
pend on the ability of the phorbol ester to activate 
protein kinase C, as analogs that lack tumorigenic 
and protein kinase C stimulatory activities do not 
inhibit cell activation. We have thus taken advan- 
tage of the demonstrated inhibitory activity of 
polymyxin B towards protein kinase C to probe 
further into the mechanism of inhibition of cell 
function by phorbol esters. The experiment whose 
results are shown in fig.3 was designed to examine 
the effect of polymyxin B on the inhibition of 
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Fig.3. Effect of polymyxin B on the inhibition by PMA 
of the secretory response of rabbit neutrophils to the ad- 
dition of fMet-Leu-Phe and cytochalasin B. The cells 
were preincubated with polymyxin B for 10 min; PMA 
(50 ng/ml) was added to the desired suspensions and the 
incubation carried out for an additional 3 min. The cells 
were then transferred to tubes containing serially diluted 
concentrations of fMet-Leu-Phe and 2.5 pug/ml 
cytochalasin B. The data are from a single experiment 
representative of at least 3 others similarly designed. 
neutrophil secretory responsiveness towards fMet- 
Leu-Phe. PMA can clearly be seen to diminish the 
secretory response of the cells induced by the 
chemotactic factor (decreased maximal release and 
shift in the EDSO). Polymyxin B, by itself, and as 
illustrated in fig.2, slightly potentiates the de- 
granulation response. When added before the 
phorbol ester, polymyxin B can be seen to prevent 
in great part the inhibitory action of the phorbol 
ester. These results support the contention that the 
inhibition of cell functions by PMA that have been 
documented in a variety of cell systems do indeed 
stem from the ability of these compounds to in- 
teract with protein kinase C. 
There are several possible interpretations to the 
data presented above. The most literal would be 
that protein kinase C, though present in the 
neutrophils [13,14] and activated upon the addi- 
tion of chemotactic factors [7&l l] is not neces- 
sary for the degranulation response of the cells that 
is evoked by chemoattractants. The function of the 
kinase would, according to this interpretation, still 
have to be defined. An alternative explanation is 
that there are different classes of protein kinase C 
and that polymyxin B does not affect the subset 
that is utilized by fMet-Leu-Phe. A third possibili- 
ty is that polymyxin B is a weak agonist for protein 
kinase C, capable of blocking the binding of PMA 
to this enzyme but not of activating it sufficiently 
to produce a detectable biological response. This 
interpretation would explain the slight potentiation 
of the secretion of N-acetyl-,&glucosaminidase that 
was observed when fMet-Leu-Phe was the secreta- 
gogue. Firstly, it should be pointed out that one 
cannot completely rule out the possibility that the 
increase in calcium induced by chemotactic factors 
overcomes the inhibition of protein kinase C by 
polymyxin B. This hypothesis is however weakened 
significantly by the in vitro finding that the an- 
tibiotic antagonizes the activation of protein 
kinase C in the presence of 0.5 mM calcium 131. 
Sorting out these alternative hypotheses requires 
much additional experimentation. However, as 
they stand, the present results indicate that caution 
needs to be exercised regarding the possible physio- 
logical role of protein kinase C in the physiological 
activation of the neutrophils. 
With respect to the commonly observed inhibi- 
tion of cell function by phorbol esters that has 
been observed in a wide variety of systems (e.g. 
229 
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[15-17]), including the chemotactic factor stimul- 
ated neutrophils, the present results strongly sug- 
gest that this apparent negative feedback is mediat- 
ed by the activation of protein kinase C. The latter 
may result in the phosphorylation of the guanine 
nucleotide binding proteins that have recently been 
implicated in signal transmission in calcium- 
dependent cells such as the neutrophils [ 18-201, the 
mast cells [21] and the platelets [22], and thereby 
interrupt the transfer of information across the 
plasma membrane. 
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